Clinical trial
Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV…
NCT00078442 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00078442 |
|---|---|
| Title | Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People |
| Official title | A Phase II Open-Label Pilot Trial of the Antiretroviral Activity, Safety, and Tolerability of Pegylated Interferon Alfa-2A (40KD) [PegasysTM] in HIV-1 Infected Subjects |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Pegylated interferon alfa-2a |
| Enrollment | 12 |
| Start date | May 1, 2006 |
| Primary completion | Jan 1, 2007 |
| First posted | Feb 26, 2004 |
| Last update posted | Aug 7, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: